These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 28392848)
21. Beyond Cost-Benefit Analysis in the Governance of Synthetic Biology. Wallach W; Saner M; Marchant G Hastings Cent Rep; 2018 Jan; 48 Suppl 1():S70-S77. PubMed ID: 29453841 [TBL] [Abstract][Full Text] [Related]
22. Images of synthetic life: Mapping the use and function of metaphors in the public discourse on synthetic biology. Braun M; Fernau S; Dabrock P PLoS One; 2018; 13(6):e0199597. PubMed ID: 29928050 [TBL] [Abstract][Full Text] [Related]
23. Professionalization as a governance strategy for synthetic biology. Weir L; Selgelid MJ Syst Synth Biol; 2009 Dec; 3(1-4):91-7. PubMed ID: 19816804 [TBL] [Abstract][Full Text] [Related]
24. Intellectual property rights, standards and data exchange in systems biology: Reflections from the IP Expert Meeting at the University of Luxembourg, 8-9 October 2015, ERASysAPP - ERA-Net for Systems Biology Applications. van Zimmeren E; Rutz B; Minssen T Biotechnol J; 2016 Dec; 11(12):1477-1480. PubMed ID: 27966844 [TBL] [Abstract][Full Text] [Related]
25. An overview of the role of society and risk in xenotransplantation. Sobbrio P; Jorqui M Xenotransplantation; 2014; 21(6):523-32. PubMed ID: 25040770 [TBL] [Abstract][Full Text] [Related]
26. Synthetic biology between challenges and risks: suggestions for a model of governance and a regulatory framework, based on fundamental rights. Colussi IA Rev Derecho Genoma Hum; 2013; (38):185-214. PubMed ID: 24340832 [TBL] [Abstract][Full Text] [Related]
27. Fostering Conversation about Synthetic Biology Between Publics and Scientists: A Comparison of Approaches and Outcomes. Todd K; Haupt G; Kollmann EK; Pfeifle S J Microbiol Biol Educ; 2018; 19(1):. PubMed ID: 29904531 [TBL] [Abstract][Full Text] [Related]
28. Co-evolution of physical and social sciences in synthetic biology. Trump BD; Cegan J; Wells E; Poinsatte-Jones K; Rycroft T; Warner C; Martin D; Perkins E; Wood MD; Linkov I Crit Rev Biotechnol; 2019 May; 39(3):351-365. PubMed ID: 30727764 [TBL] [Abstract][Full Text] [Related]
29. [Evidence-based policy and sustainable translation of knowledge: a perspective for health promotion in Germany]. Rütten A; Gelius P Gesundheitswesen; 2012 Apr; 74(4):224-8. PubMed ID: 22508260 [TBL] [Abstract][Full Text] [Related]
30. Advancing the WHO-INTEGRATE Framework as a Tool for Evidence-Informed, Deliberative Decision-Making Processes: Exploring the Views of Developers and Users of WHO Guidelines. Stratil JM; Paudel D; Setty KE; Menezes de Rezende CE; Monroe AA; Osuret J; Scheel IB; Wildner M; Rehfuess EA Int J Health Policy Manag; 2022 May; 11(5):629-641. PubMed ID: 33131223 [TBL] [Abstract][Full Text] [Related]
31. Stakeholder Involvement in the Governance of Human Genome Editing in Japan. Aikyo T; Kogetsu A; Kato K Asian Bioeth Rev; 2023 Oct; 15(4):431-455. PubMed ID: 37808450 [TBL] [Abstract][Full Text] [Related]
32. Examining expertise: Synthetic biology experts' perceptions of risk, benefit, and the public for research and applications regulation. Wirz CD; Howell EL; Scheufele DA; Brossard D; Xenos MA Public Underst Sci; 2023 Oct; 32(7):870-888. PubMed ID: 37204058 [TBL] [Abstract][Full Text] [Related]
33. Research Stakeholders' Views on Benefits and Challenges for Public Health Research Data Sharing in Kenya: The Importance of Trust and Social Relations. Jao I; Kombe F; Mwalukore S; Bull S; Parker M; Kamuya D; Molyneux S; Marsh V PLoS One; 2015; 10(9):e0135545. PubMed ID: 26331716 [TBL] [Abstract][Full Text] [Related]
34. Anticipating governance challenges in synthetic biology: Insights from biosynthetic menthol. Ribeiro B; Shapira P Technol Forecast Soc Change; 2019 Feb; 139():311-320. PubMed ID: 30774160 [TBL] [Abstract][Full Text] [Related]
35. Meaning of Ambiguity: A Japanese Survey on Synthetic Biology and Genome Editing. Hibino A; Yoshizawa G; Minari J Front Sociol; 2019; 4():81. PubMed ID: 33869403 [TBL] [Abstract][Full Text] [Related]
36. Prospective Technology Assessment of Synthetic Biology: Fundamental and Propaedeutic Reflections in Order to Enable an Early Assessment. Schmidt JC Sci Eng Ethics; 2016 Aug; 22(4):1151-1170. PubMed ID: 26160061 [TBL] [Abstract][Full Text] [Related]
37. Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions. Gauvreau CL; Wight L; Subasri M; Palmer A; Hayeems R; Croker A; Abelson J; Fraser B; Bombard Y; Moore Hepburn C; Wilson MG; Denburg A Health Expect; 2023 Apr; 26(2):715-727. PubMed ID: 36639959 [TBL] [Abstract][Full Text] [Related]
38. Review of quantitative and qualitative studies on U.S. public perceptions of synthetic biology. Pauwels E Syst Synth Biol; 2009 Dec; 3(1-4):37-46. PubMed ID: 19816798 [TBL] [Abstract][Full Text] [Related]
39. Towards Preventing and Managing Conflict of Interest in Nutrition Policy? An Analysis of Submissions to a Consultation on a Draft WHO Tool. Ralston R; Hil SE; da Silva Gomes F; Collin J Int J Health Policy Manag; 2021 Mar; 10(5):255-265. PubMed ID: 32610752 [TBL] [Abstract][Full Text] [Related]